Anaplastic Ganglioglioma — Trials

Anaplastic Ganglioglioma — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 50%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03975829	Pediatric Long-Term Follow-up and Rollover Study	active not recruiting	Phase 4	163	Novartis PharmaceuticalsINDUSTRY	19	Aug 27, 2026	clinicaltrials
NCT03919071	Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma	active not recruiting	Phase 2	58	National Cancer Institute (NCI)NIH	2	Jul 10, 2026	clinicaltrials